Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Is it possible to predict HCV-related liver cirrhosis non-invasively through routine laboratory parameters?

Gentile I, Buonomo AR, Zappulo E, Borgia G.

Infez Med. 2014 Mar;22(1):11-8. Review.

2.

[Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis].

Pár G, Trosits A, Pakodi F, Szabó I, Czimmer J, Illés A, Gódi S, Bajor J, Sarlós P, Kenyeres P, Miseta A, Vincze A, Pár A.

Orv Hetil. 2014 Feb 16;155(7):270-6. doi: 10.1556/OH.2014.29824. Hungarian.

PMID:
24509356
3.

FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy.

Shaheen AA, Wan AF, Myers RP.

Am J Gastroenterol. 2007 Nov;102(11):2589-600. Epub 2007 Sep 10. Review.

PMID:
17850410
4.

[Noninvasive methods for predicting liver fibrosis in patients with chronic hepatitis C: alternatives to liver biopsy].

Halfon P, Bourlière M, Pénaranda G, Cacoub P.

Presse Med. 2007 Mar;36(3 Pt 2):457-66. Epub 2007 Feb 8. Review. French.

PMID:
17291712
5.

Prospective evaluation of liver fibrosis in chronic viral hepatitis C infection using the Sabadell NIHCED (Non-Invasive Hepatitis-C-Related Cirrhosis Early Detection) index.

Bejarano G, Vergara M, Dalmau B, Puig J, Bella MR, Suárez D, Calvet X.

Rev Esp Enferm Dig. 2009 May;101(5):325-35. English, Spanish.

6.

Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?

Resino S, Bellón JM, Asensio C, Micheloud D, Miralles P, Vargas A, Catalán P, López JC, Alvarez E, Cosin J, Lorente R, Muñoz-Fernández MA, Berenguer J.

BMC Infect Dis. 2010 Aug 19;10:244. doi: 10.1186/1471-2334-10-244.

7.

Hepatitis B: liver fibrosis and hepatocellular carcinoma.

Lok AS.

Gastroenterol Clin Biol. 2009 Oct-Nov;33(10-11):911-5. doi: 10.1016/j.gcb.2009.06.001. Epub 2009 Jul 4.

8.

Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.

Castéra L, Le Bail B, Roudot-Thoraval F, Bernard PH, Foucher J, Merrouche W, Couzigou P, de Lédinghen V.

J Hepatol. 2009 Jan;50(1):59-68. doi: 10.1016/j.jhep.2008.08.018. Epub 2008 Oct 26.

PMID:
19013661
9.

Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.

Bruno S, Zuin M, Crosignani A, Rossi S, Zadra F, Roffi L, Borzio M, Redaelli A, Chiesa A, Silini EM, Almasio PL, Maisonneuve P.

Am J Gastroenterol. 2009 May;104(5):1147-58. doi: 10.1038/ajg.2009.31. Epub 2009 Apr 7.

PMID:
19352340
10.

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

Ngo Y, Munteanu M, Messous D, Charlotte F, Imbert-Bismut F, Thabut D, Lebray P, Thibault V, Benhamou Y, Moussalli J, Ratziu V, Poynard T.

Clin Chem. 2006 Oct;52(10):1887-96. Epub 2006 Aug 24.

11.

Improved fibrosis staging by elastometry and blood test in chronic hepatitis C.

Calès P, Boursier J, Ducancelle A, Oberti F, Hubert I, Hunault G, de Lédinghen V, Zarski JP, Salmon D, Lunel F; ANRS HC EP 23 Fibrostar Study.

Liver Int. 2014 Jul;34(6):907-17. doi: 10.1111/liv.12327. Epub 2013 Oct 16.

PMID:
24102852
12.

Comparison of accuracy of fibrosis degree classifications by liver biopsy and non-invasive tests in chronic hepatitis C.

Boursier J, Bertrais S, Oberti F, Gallois Y, Fouchard-Hubert I, Rousselet MC, Zarski JP, Calès P.

BMC Gastroenterol. 2011 Nov 30;11:132. doi: 10.1186/1471-230X-11-132.

13.

Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.

Posthouwer D, Mauser-Bunschoten EP, Fischer K, VAN Erpecum KJ, DE Knegt RJ.

J Thromb Haemost. 2007 Jan;5(1):25-30.

14.

Comparison of acoustic radiation force impulse imaging with transient elastography for the detection of complications in patients with cirrhosis.

Vermehren J, Polta A, Zimmermann O, Herrmann E, Poynard T, Hofmann WP, Bojunga J, Sarrazin C, Zeuzem S, Friedrich-Rust M.

Liver Int. 2012 May;32(5):852-8. doi: 10.1111/j.1478-3231.2011.02736.x. Epub 2011 Dec 30.

PMID:
22222050
15.

Ultrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UK.

Canavan C, Eisenburg J, Meng L, Corey K, Hur C.

Dig Dis Sci. 2013 Sep;58(9):2691-704. doi: 10.1007/s10620-013-2705-y. Epub 2013 May 30.

16.

Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C.

Smith JO, Sterling RK.

Aliment Pharmacol Ther. 2009 Sep 15;30(6):557-76. doi: 10.1111/j.1365-2036.2009.04062.x. Epub 2009 Jun 10. Review.

17.

Fibroscan and FibroTest/FibroMax to assess liver fibrosis/cirrhosis in patients with chronic HBV and HCV infection in Georgia.

Dolmazashvili E, Zhamutashvili M, Svanidze M, Nizharadze N, Abutidze A.

Georgian Med News. 2008 Dec;(165):83-7.

PMID:
19124923
18.

A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.

Ahmad W, Ijaz B, Gull S, Asad S, Khaliq S, Jahan S, Sarwar MT, Kausar H, Sumrin A, Shahid I, Hassan S.

Virol J. 2011 Feb 8;8:53. doi: 10.1186/1743-422X-8-53. Review.

20.

Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).

Degos F, Perez P, Roche B, Mahmoudi A, Asselineau J, Voitot H, Bedossa P; FIBROSTIC study group.

J Hepatol. 2010 Dec;53(6):1013-21. doi: 10.1016/j.jhep.2010.05.035. Epub 2010 Aug 14.

PMID:
20850886
Items per page

Supplemental Content

Write to the Help Desk